| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | Director | Common shares without par value | 6.73M | $893M | $132.65 | 25 Apr 2025 | Direct |
| ABBOTT LABORATORIES | Director | Common shares without par value | 6.73M | $797M | $118.50 | 26 Apr 2024 | Direct |
| ABBOTT LABORATORIES | Director | Common shares without par value | 258 | $34.2K | $132.65 | 25 Apr 2025 | Alynne Starks 2012 Irrevocable Trust |
| ABBOTT LABORATORIES | Director | Common shares without par value | 258 | $30.6K | $118.50 | 26 Apr 2024 | Alynne Starks 2012 Irrevocable Trust |
| ABBOTT LABORATORIES | Director | Option (right to buy) | 5.28K | 26 Apr 2024 | Direct | ||
| ABBOTT LABORATORIES | Director | Option (right to buy) | 4.52K | 25 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25 Apr 2025 | 2 | $0 | 4 | Director | 29 Apr 2025, 18:22 |
| ABT | ABBOTT LABORATORIES | 26 Apr 2024 | 2 | $0 | 4 | Director | 30 Apr 2024, 18:22 |
| ABT | ABBOTT LABORATORIES | 26 Oct 2023 | 2 | -$4.7M | 4 | Director | 30 Oct 2023, 16:58 |
| ABT | ABBOTT LABORATORIES | 27 Jul 2023 | 2 | -$5.69M | 4 | Director | 28 Jul 2023, 17:10 |
| ABT | ABBOTT LABORATORIES | 28 Apr 2023 | 4 | -$5.55M | 4 | Director | 02 May 2023, 20:04 |
| ABT | ABBOTT LABORATORIES | 27 Oct 2022 | 2 | -$4.87M | 4 | Director | 31 Oct 2022, 17:44 |
| ABT | ABBOTT LABORATORIES | 26 Jul 2022 | 2 | -$5.46M | 4 | Director | 28 Jul 2022, 17:20 |
| ABT | ABBOTT LABORATORIES | 03 May 2022 | 3 | -$5.66M | 4 | Director | 05 May 2022, 17:15 |
| ABT | ABBOTT LABORATORIES | 29 Apr 2022 | 1 | $0 | 4 | Director | 03 May 2022, 18:23 |